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Abstract Therapeutic glycoprotein production in the widely
used expression host Pichia pastoris is hampered by the
differences in the protein-linked carbohydrate biosynthesis
between this yeast and the target organisms such as man. A
significant step towards the generation of human-compatible
N-glycans in this organism is the conversion of the yeast-type
high-mannose glycans to mammalian-type high-mannose and/or
complex glycans. In this perspective, we have co-expressed an
endoplasmic reticulum-targeted Trichoderma reesei 1,2-K-D-
mannosidase with two glycoproteins: influenza virus haemagglu-
tinin and Trypanosoma cruzi trans-sialidase. Analysis of the
N-glycans of the two purified proteins showed a s 85% decrease
in the number of K-1,2-linked mannose residues. Moreover, the
human-type high-mannose oligosaccharide Man5GlcNAc2 was
the major N-glycan of the glyco-engineered trans-sialidase,
indicating that N-glycan engineering can be effectively accom-
plished in P. pastoris. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Asparagine-linked glycosylation is a structurally highly
complex co- and post-translational modi¢cation of glycopro-
teins. These glycans modulate the folding and sorting in the
secretory pathway of the proteins to which they are attached
[1]. When the glycoprotein is secreted, the structure of these
glycans contributes to its pharmacodynamic and pharmacoki-
netic behaviour (tissue distribution, peak levels and residence
time in the blood stream) [2]. Therefore, for optimal thera-
peutic e⁄cacy of recombinant glycoproteins, a cognate glyco-
sylation pattern is often desirable. This is one of the main
reasons for the use of expensive animal cell culture techniques
for the production of these therapeutics.
Alternatives are being sought in insect cell culture and in
the use of eukaryotic microorganisms such as yeasts (mainly
Saccharomyces cerevisiae and Pichia pastoris) and ¢lamentous
fungi (mainly of the genera Aspergillus, Penicillium and Tri-
choderma). Both insect cells and fungal species have the basic
biosynthetic machinery [3] for constructing N-glycans [4,5] but
they lack partially (insect cells) [6] or completely (fungal cells)
the capability of constructing fully modi¢ed complex-type N-
glycans. It is clear that bio-engineering of these host cells will
be needed to tackle this problem if they are to be used in the
production of glycoproteins for therapeutic use [7,8].
As for yeasts, earlier and ongoing work in other groups
[7,9] focused on the glyco-engineering of S. cerevisiae. The
eventual yeast strain produced about 20% Man5GlcNAc2 on
the yeast carboxypeptidase Y after four engineering steps [7].
It remains to be seen, however, if the created S. cerevisiae
strain will be useful for the production of recombinant glyco-
proteins, as the required engineering steps are severely a¡ect-
ing the yeast’s viability and growth characteristics.
Compared to S. cerevisiae, P. pastoris has several advan-
tages with respect to N-glycosylation. Generally, the high-
mannose N-glycans of this yeast tend to be signi¢cantly less
elaborate than those of S. cerevisiae. Several recombinant gly-
coproteins have been reported to be glycosylated partly with
the Man8GlcNAc2 ER-exit N-glycan, probably indicating a
lower activity of the Golgi mannosyltransferases in Pichia.
Importantly, and in contrast to the situation with S. cerevisi-
ae, no hyper-immunogenic terminal K-1,3-linked mannoses
are incorporated in the N-glycans on glycoproteins produced
by P. pastoris. Successful expression of hundreds of heterolo-
gous proteins has been reported for this yeast [10]. Therefore,
we are developing short-cut glyco-engineering strategies in the
yeast P. pastoris. Here we present results describing the co-
expression of an ER-retained Trichoderma reesei K-1,2-D-man-
nosidase with two heterologous glycoproteins: in£uenza virus
haemagglutinin and Trypanosoma cruzi trans-sialidase.
2. Materials and methods
2.1. Strains and plasmids
For localisation studies of the c-Myc-HDEL-tagged variant of the
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mannosidase, P. pastoris strain PPY12OH was used (kindly provided
by Benjamin Glick) [11]. This strain constitutively expresses a variant
of the S. cerevisiae OCH1 K-1,6-mannosyltransferase, provided with a
triple C-terminal haemagglutinin (HA) derived tag. The OCH1-HA
protein localises to the early Golgi apparatus in P. pastoris and serves
as a marker protein for this organelle. For co-expression of the
HDEL-tagged variant of the mannosidase with in£uenza virus haem-
agglutinin, a P. pastoris GS115 (Invitrogen, Baarn, The Netherlands)
strain expressing a soluble form of the A/Victoria/3/75 (H3N2-sub-
type) haemagglutinin [12] was used. The T. cruzi trans-sialidase ex-
pression strain was recently described [13]. All recombinant DNA
procedures were performed according to standard procedures [14].
The GenBank accession number of the complementary DNA se-
quence of the T. reesei mannosyl oligosaccharide 1,2-K-mannosidase
(EC 3.2.1.113) is AF212153. A construction fragment was generated
using polymerase chain reaction (PCR) on the pPIC9MFmannase
plasmid [15] using the following oligonucleotide primers: 5P-GA-
CTGGTTCCAATTGACAAGC-3P and 5P-AGTCTAGATTACAAC-
TCGTCGTGAGCAAGGTGGCCGCCCCGTCG-3P. The resulting
product contains the 3P end of the P. pastoris alcohol dehydrogenase
1 (AOX1) promoter, the prepro signal sequence of the S. cerevisiae
K-mating factor, the open reading frame of the T. reesei 1,2-K-man-
nosidase cloned in frame with the signal sequence, the coding se-
quence for HDEL, a stop codon and an XbaI restriction site. This
fragment was digested with EcoRI and XbaI, removing the 5P sequen-
ces up to the mannosidase open reading frame (ORF), and cloned in
the vector pGAPZKA (Invitrogen, Baarn, The Netherlands), also di-
gested with EcoRI and Xba, thus restoring the fusion with the
S. cerevisiae K-mating factor signal sequence. The resulting plasmid
was named pGAPZMFManHDEL and the entire generated open
reading frame was sequenced using standard methodology. In order
to introduce the coding sequence for a c-Myc tag between the cata-
lytic domain and the HDEL signal, the 3P end of the ORF of T. reesei
1,2-K-mannosidase was ampli¢ed using PCR with the sense oligonu-
cleotide primer 5P-CCATTGAGGACGCATGCCGCGCC-3P (con-
taining an SphI restriction site) and antisense oligonucleotide primer
5P-TTCATCATCACGACGGGGCGGCCACCTTGCTGAACAAA-
AACTCATCTCAGAAGAGGATCTGCACGACGAGTTGTAATC-
TAGATAC-3P (containing the coding sequences of the c-Myc tag and
the HDEL signal, followed by a stop codon and an XbaI restriction
site). The resulting PCR product was digested with SphI and XbaI,
puri¢ed by agarose gel electrophoresis and ligated in pGAPZMF-
ManHDEL, which had been opened with the same restriction en-
zymes, resulting in plasmid pGAPZMFManMycHDEL. The part of
the resulting open reading frame that originated from PCR ampli¢-
cation was sequenced. To bring this ORF under control of the induc-
ible alchohol oxidase I (AOXI) promoter, the entire ORF was liber-
ated from pGAPZMFManMycHDEL with BstBI and XbaI and
cloned in pPICZB, digested with the same enzymes (Invitrogen,
Baarn, The Netherlands), resulting in pPICZMFManMycHDEL.
2.2. Transformations and genomic analysis
Plasmids pGAPZMFManHDEL and pGAPZMFManMycHDEL
were linearised using AvrII to direct integration in the P. pastoris
GAP promotor. pPICZMFManHDEL was linearised with PmeI to
direct integration in the Pichia AOXI promotor. All transformations
to P. pastoris were performed with electroporation according to the
directions of Invitrogen. Genomic integration of the expression cas-
settes was con¢rmed using PCR and Southern blotting (results not
shown) on genomic DNA puri¢ed from the Pichia strains using the
Nucleon Yeast Miniprep method (Amersham Life Science, Little
Chalfont, UK).
2.3. Sodium dodecyl sulphate^polyacrylamide gel electrophoresis
(SDS^PAGE) and Western blotting
Total yeast cell lysates were prepared by washing the cells free of
growth medium twice in phosphate bu¡ered saline, followed by boil-
ing in 1 volume of 2U concentrated Laemmli loading bu¡er for 5 min.
For the analysis of protein content of the growth media, the proteins
were precipitated from 200 Wl of these media using desoxycholate/
trichloro-acetic acid. The pellets were redissolved in 2U concentrated
Laemmli loading bu¡er and the solutions were pH-corrected using
Tris. SDS^PAGE was performed, followed by semi-dry electroblot-
ting to nitrocellulose membranes. For Western blotting, the 9E10 anti-
Myc monoclonal antibody was used at a concentration of 1 Wg/ml and
the secondary antibody was goat anti-mouse immunoglobulin G con-
jugated to alkaline phosphatase. Detection was obtained with nitro
blue tetrazolium/5-bromo-4-chloro-indolylphosphate.
2.4. Immuno£uorescence microscopy
The procedure used essentially follows described methods [16].
Brie£y, yeast cultures were grown to OD600 = 0.8 in growth medium
containing 1% yeast extract, 2% peptone (both from Difco, Detroit,
MI, USA), 2% glucose and 100 Wg/ml Zeocin (Invitrogen). Formal-
dehyde was added to the yeast cultures to a ¢nal concentration of 4%
and incubated for 10 min at room temperature. Cells were pelleted
and resuspended in 50 mM potassium phosphate bu¡er pH 6.5 con-
taining 1 mM MgCl2 and 4% formaldehyde and incubated for 2 h at
room temperature. After pelleting, the cells were resuspended to an
OD600 = 10 in 100 mM potassium phosphate bu¡er pH 7.5 containing
1 mM MgCl2 and ethylenediaminetetraacetate-free complete protease
inhibitor cocktail (Boehringer-Mannheim). To 100 Wl of cell suspen-
sion, 0.6 Wl of L-mercaptoethanol and 20 Wl of a 20 000 U/ml solution
of zymolyase 100T (ICN Biomedicals, Asse-Relegem, Belgium) were
added, followed by a 25 min incubation with gentle shaking. The cells
were washed twice in the incubation bu¡er and added to poly-D-lysine
(Sigma, Bornem, Belgium) coated coverslips (‘wells’ are created on the
coverslips using adhesive rings normally in use for reinforcing perfo-
rations in paper). Excess liquid was blotted with a cotton swab and
the cells were allowed to dry at 320‡C. All blocking, antibody incu-
bation and washing steps were performed in phosphate bu¡ered saline
containing 0.05% bovine serum albumin. The primary 9E10 anti-Myc
and 12CA5 anti-HA monoclonal antibodies were used at a concen-
tration of 2 Wg/ml and the secondary goat anti-mouse monoclonal
antibody conjugated to £uorescein isothiocyanate (Molecular Probes,
Leiden, The Netherlands) was used at 5 Wg/ml. After ¢xation and cell
wall permeabilisation, the integrity of the yeast cell morphology was
checked in phase contrast microscopy. After immunostaining, the
coverslips were mounted in VectaShield medium containing
HOECHST 33258, which stains DNA and provides for nuclear local-
isation. The slides were examined under a Zeiss Axiophot £uorescence
microscope (Carl Zeiss, Go«ttingen, Germany) equipped with an Im-
agePoint charge coupled device camera (Photometrics, Mu«nchen, Ger-
many). Images were processed using Macprobe 4.0 software (Percep-
tive Scienti¢c Instruments, League City, TX, USA) and prepared with
Corel Photopaint 9.0.
2.5. Expression and puri¢cation of glyco-engineered recombinant
proteins
The expression cassette for T. reesei mannosidase-HDEL under
control of the constitutive GAP promotor was transformed to strains
expressing S. cerevisiae K-mating factor signal sequence fusions with
either the in£uenza A/Victoria/3/75 (H3N2-subtype) haemagglutinin
[12] or the T. cruzi trans-sialidase [13] coding sequences. Fermentation
and protein puri¢cation was according to the procedures described in
these citations, with the exception that we omitted the ¢nal Mono-Q
anion exchange step in the trans-sialidase puri¢cation to avoid remov-
al of protein with phosphorylated N-glycans, which would bias our
N-glycan engineering results. The resulting products were over 95%
pure as evidenced by SDS^PAGE and Coomassie brilliant blue stain-
ing.
2.6. Carbohydrate analysis
The analysis was performed according to a procedure recently de-
veloped in our laboratory [17]. Brie£y, the glycoproteins were bound
to the polyvinylidenedi£uoride membrane in the wells of a 96-well
plate, reduced, alkylated and submitted to peptide-N-glycosidase F
deglycosylation. The glycans were derivatised with 8-amino-1,3,6-pyr-
enetrisulfonic acid by reductive amination. Subsequently, the excess
free label was removed using Sephadex G10-packed spin columns and
the glycans were analysed by electrophoresis on a 36 cm sequencing
gel on an ABI 377A DNA-sequencer and detected using the built-in
argon laser. Digests with 3 mU/ml puri¢ed T. reesei 1,2-K-mannosi-
dase [15] were performed in 20 mM sodium acetate pH 5.0. The
glycans derived from 1 Wg of the puri¢ed recombinant glycoproteins
were used as the substrate. 1 U of the 1,2-K-mannosidase is de¢ned as
the amount of enzyme that releases 1 Wmol of mannose from baker’s
yeast mannan per min at 37‡C and pH 5.0.
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3. Results and discussion
3.1. Expression of HDEL-tagged mannosidase in P. pastoris
In order for an 1,2-D-K-mannosidase to be active in meta-
bolic engineering of the yeast N-glycosylation pathway to-
wards the biosynthesis of a mammalian-type high-mannose
glycan type, this mannosidase has to be targeted to the ap-
propriate compartment in the secretory pathway. Ideally, the
1,2-K-D-mannosidase activity should be located where the
common eukaryotic endoplasmic reticulum Man8GlcNAc2
‘exit’ N-glycan structure is formed but where it has not yet
reached the yeast Golgi glycosyltransferases (mainly manno-
syltransferases and phosphomannosyltransferases [18]). In-
deed, it has been shown that the Man5GlcNAc2 end-product
of 1,2-D-K-mannosidase digestion of the Man8GlcNAc2 pre-
cursor is no longer a substrate for any glycosyltransferase in
the P. pastoris Golgi apparatus [19]. This strategy is illustrated
in Fig. 1. In this study, we used the HDEL retention system in
P. pastoris to target the K-1,2-mannosidase activity to the ER
Golgi transit region.
To evaluate the expression and the ER retention e⁄ciency
of the c-Myc-tagged transgenes, Western blotting was per-
formed on total cell lysates and on growth media (Fig. 2A).
The T. reesei mannosidase expressed in P. pastoris is hyper-
glycosylated [15], accounting for the extensive smearing of the
bands in Fig. 2A. In our laboratory, the least hyperglycosy-
lated glycoforms of a secreted version of the protein were
puri¢ed and the molecular weight of the major glycoform in
this puri¢ed preparation was 60 922, as measured by MALDI-
TOF-MS (unpublished observation). Taking into account that
the intracellularly retained version of the protein observed
here is 30 amino acids longer than the secreted version, the
molecular weight of the glycoforms with lowest molecular
weight detected on the Western blot matches well with the
expected value deduced from the mass spectrometrical mea-
surement.
From these Western blotting results, we conclude that the
HDEL-tagged mannosidase was retained intracellularly, both
when expressed from the strong constitutive GAP promoter
(compare lanes 1, 2 with 6, 7) and from the strong methanol-
inducible AOXI promoter (lanes 4, 5 and 9, 10). The small
amount of the protein observed in the growth medium can
either be due to some cell lysis during the culture period or to
a minimal over£ow of the HDEL retention system. We con-
sistently observed that more of the mannosidase-Myc-HDEL
was found in the growth medium when the gene expression
was driven by the inducible AOXI promotor as compared to
the constitutive GAP promotor (Fig. 2). This observation may
be explained by the toxicity of methanol in the induction
phase of AOXI. Therefore, further experiments were con-
ducted with the mannosidase under control of the GAP pro-
motor. Due to the unavailability of suitable antibodies, West-
ern blotting could not be used to check the expression of the
transgenes not containing a c-Myc tag coding sequence. Ex-
Fig. 1. Strategy for conversion of the P. pastoris N-glycan biosynthesis pathway towards biosynthesis of a mammalian-type high-mannose
N-glycan. The pathway representation is based on knowledge derived from S. cerevisiae N-glycan biosynthesis analysis. Black squares represent
K-1,2-linked mannose residues, white squares represent K-1,3/6-linked mannose residues and white circles represent N-acetylglucosamine resi-
dues. The upper half of the drawing describes the situation in non-glyco-engineered yeast. In the endoplasmic reticulum, one K-1,2-linked man-
nose residue is cleaved from the precursor N-glycan Man9GlcNAc2 before transport of the glycoproteins to the cis-Golgi apparatus. There, the
yeast OCH1 1,6-K-mannosyltransferase initiates the biosynthesis of yeast-type high-mannose glycans by transferring one mannose residue in
K-1,6-linkage to the Man8GlcNAc2 ER-exit structure. The lower half of the drawing represents the objective of our pathway engineering: by in-
troduction of a potent ER-retained 1,2-K-mannosidase activity, capable of removing all K-1,2-linked mannose residues, the human-type Man5-
GlcNAc2 structure is formed, which is not a substrate for any Pichia Golgi mannosyltransferase [19]. This leads to the secretion of glycopro-
teins modi¢ed with this human-type high-mannose N-glycan. ER targeting of the mannosidase is achieved using the C-terminal HDEL se-
quence, which is recognised by the HDEL receptor. This receptor^ligand complex is recycled to the ER in a COP I-dependent pathway.
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pression of these transgenes was con¢rmed on the mRNA
level by Northern blot analysis (not shown).
Importantly, no growth defects were observed for any of
the recombinant yeast strains, indicating that the mannosidase
transgenes are not toxic to P. pastoris. This property is very
important if the developed strains are to be used for large-
scale fermentations.
3.2. Subcellular localisation of mannosidase-Myc-HDEL
In P. pastoris, proteins localised in the endoplasmic reticu-
lum show a circonuclear staining pattern on immuno£uores-
cence microscopy, whereas proteins with a steady-state distri-
bution in the cis-Golgi apparatus show a dotty pattern,
exempli¢ed by an HA-tagged variant of the S. cerevisiae
OCHI K-1,6-mannosyltransferase ([11] and Fig. 2B.1). As
shown in Fig. 2B.2, the mannosidase-Myc-HDEL localises
in a circular pattern around the nucleus (HOECHST 33258
DNA stain not shown to allow greyscale reproduction), indi-
cating a predominant endoplasmic reticulum targeting, con-
sistent with HDEL-mediated ER targeting.
3.3. Co-expression of mannosidase-HDEL with recombinant
glycoproteins
To test our hypothesis that it would be feasible to obtain
the Man5GlcNAc2 N-glycan on glycoproteins which are nor-
mally glycosylated with Man8GlcNAc2, the T. reesei manno-
sidase-HDEL under control of the strong constitutive GAP
promoter was introduced in a P. pastoris strain expressing the
T. cruzi trans-sialidase under control of the strong inducible
AOXI promotor. The major N-glycan on this protein is
Man8GlcNAc2, as can be seen in Fig. 3B. In vitro, this glycan
is digestible to Man5GlcNAc2 with 1,2-K-D-mannosidase
(Fig. 3C). In the N-glycan pro¢le of the trans-sialidase, co-
expressed with mannosidase-HDEL, the major peak corre-
sponds to Man5GlcNAc2 (Fig. 3D). For comparison, Fig.
3F shows the N-glycan pattern of bovine RNAse B, consisting
of high-mannose-type glycans ranging in size from Man5-
GlcNAc2 to Man8GlcNAc2.
The same mannosidase-HDEL construct was also intro-
Fig. 2. HDEL-tagged T. reesei 1,2-K-mannosidase is retained intra-
cellularly in P. pastoris. A: Western blotting. Yeast strains were
grown in 10 ml yeast extract/peptone/glycerol growth medium
(YPG) cultures to an OD600 = 10, diluted ¢ve-fold and grown in
yeast extract/peptone/methanol induction medium (YPM) for 48 h.
1/50th of the culture medium and 1/65th of the cells were analysed
by SDS^PAGE and Western blotting with the mouse monoclonal
9E10 anti-Myc antibody. The position of molecular weight marker
proteins are indicated with arrows. Lanes 1^5: cellular lysates.
Lanes 1, 2, pGAPZMFManMycHDEL transformants; lane 3, non-
transformed PPY12OH (negative control); lanes 4, 5, pPICZMF-
ManMycHDEL transformants. Lanes 6^10: culture media. Lane 6,
non-transformed PPY12OH (negative control); lanes 7, 8,
pGAPZMFManMycHDEL transformants; lanes 9, 10, pPICZMF-
ManMycHDEL transformants. B: Immuno£uorescence microscopy.
1: Phase contrast image of a P. pastoris cell (strain PPY12OH
transformed with pGAPZMFManHDEL) at 1000U magni¢cation.
The nucleus is visible as an ellipse in the lower right quadrant of
the cell. 2: Same cell as in 1, but in £uorescence microscopy mode
to show localisation of the T. reesei mannosidase-Myc-HDEL pro-
tein. The protein is mainly localised in a circular distribution
around the nucleus (nuclear envelope), which is typical for an endo-
plasmic reticulum steady-state distribution. 3: Phase contrast image
of a P. pastoris cell (strain PPY12OH transformed with pGAPZMF-
ManHDEL) at 1000U magni¢cation. 4: Same cell in £uorescence
microscopy to show localisation of the Golgi marker protein
OCH1-HA in P. pastoris strain PPY12OH. The dot-like distribution
throughout the cytoplasm, with 3^4 dots per cell is typical for cis-
Golgi distribution in P. pastoris.
Fig. 3. N-glycan analysis of T. cruzi trans-sialidase co-expressed
with T. reesei mannosidase-HDEL. A: Malto-oligosaccharide size
reference ladder. Sizes of the glycans are expressed in glucose units
(GU) by comparison of their electrophoretic mobility to the mobili-
ty of these malto-oligosaccharides. B: N-glycans derived from re-
combinant T. cruzi trans-sialidase expressed in P. pastoris. The peak
at GU = 9.2 corresponds to Man8GlcNAc2. C: Same analytes as B,
but after overnight treatment with 3 U/ml puri¢ed recombinant
T. reesei 1,2-K-mannosidase. D: N-glycans derived from recombi-
nant trans-sialidase co-expressed in P. pastoris with T. reesei manno-
sidase-HDEL (under control of the GAP promotor). The peak at
GU = 7.6 corresponds to the Man5GlcNAc2 peak in the pro¢le of
RNase B (F). E: Same analytes as D, but after overnight treatment
with 3 mU/ml puri¢ed recombinant T. reesei 1,2-K-mannosidase.
F: N-glycans derived from bovine RNase B. These glycans consist
of Man5GlcNAc2 to Man8GlcNAc2. Di¡erent isomers are resolved,
accounting for the number of peaks for Man7GlcNAc2.
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duced in a strain expressing the in£uenza A haemagglutinin
under control of the AOXI promotor. The smallest N-glycan
on this recombinant protein is an isomer of Man9GlcNAc2
(Fig. 4B), indicating that the initiating K-1,6-mannosyltrans-
ferase of P. pastoris modi¢es essentially all of the N-glycans of
haemagglutinin, in contrast with the situation with the trans-
sialidase (Fig. 3). After an in vitro 1,2-K-D-mannosidase di-
gest, the smallest glycan obtained is a Man6GlcNAc2 isomer.
Thus, as expected, the smallest sugar chain in the N-glycan
pattern of the haemagglutinin co-expressed with 1,2-K-man-
nosidase-HDEL is also a Man6GlcNAc2 isomer. Two other
abundant species are Man7GlcNAc2 and Man8GlcNAc2, of
which only a fraction is further degradable with a large excess
of the puri¢ed T. reesei mannosidase. The literature about
P. pastoris N-glycan structures learns that the major isomers
in the Man10GlcNAc2 and Man11GlcNAc2 populations on
P. pastoris glycoproteins are modi¢ed with two and three
K-1,6-linked mannose residues, respectively, on the Man8-
GlcNAc2 ER-exit structure [20]. These residues cannot be
removed by the T. reesei 1,2-K-mannosidase, explaining the
generation in vivo of the observed 1,2-K-mannosidase-unde-
gradable Man7GlcNAc2 and Man8GlcNAc2 structures (for
the proposed structural formulas: see Fig. 4). The portion
of the Man7GlcNAc2 and Man8GlcNAc2 glycans which are
still further degradable with the 1,2-K-mannosidase in vitro
were incompletely processed in vivo.
Analogous to the behaviour of Man9GlcNAc2 present on
haemagglutinin, one would expect the Man9GlcNAc2 isomer
present on the transsialidase (Fig. 3) to be processed to Man6-
GlcNAc2, too. However, this seems only partially to be the
case, as the peak corresponding to Man6GlcNAc2 in D rep-
resents a smaller percentage of the total glycans than does the
Man9GlcNAc2 peak in B. Instead, other isomers are formed
that are not observed in the corresponding haemagglutinin
pattern of Fig. 4C. These observations indicate that quantita-
tive predictions about the outcome of an in vivo glyco-engi-
neering step are di⁄cult to make. One of the main reasons for
this is our limited knowledge about the complex interplay
between folding, secretion and glycosylation.
Notwithstanding these observations, we postulate that the
one-step generation of Man5GlcNAc2 on recombinant glyco-
proteins in Pichia is feasible if a substantial fraction of the
substrate N-glycans are Man8GlcNAc2. This probably indi-
cates low activity of the initiating K-1,6-mannosyltransferase
on the glycans of these proteins. For proteins whose glycans
are e⁄ciently modi¢ed by this transferase, an inactivation of
the gene coding for the transferase will be needed. We have
made progress in this direction (unpublished results).
To estimate the e⁄ciency of removal of K-1,2-mannose res-
idues by the mannosidase-HDEL, batches of the N-glycans
derived from the trans-sialidase and haemagglutinin after co-
expression were exhaustively digested in vitro with puri¢ed
recombinant T. reesei K-1,2-mannosidase. The resulting
N-glycan pro¢les are shown in Fig. 3E and Fig. 4D, respec-
tively. From these data, we calculated that co-expression with
the T. reesei K-1,2-mannosidase-HDEL results in removal of
s 85% of the K-1,2-linked mannoses theoretically hydrolys-
able by this enzyme.
This e⁄cient glyco-engineering step indicates that it will be
feasible to obtain homogeneous N-glycans on P. pastoris pro-
duced proteins, greatly facilitating puri¢cation (easier down-
stream processing due to more homogeneous product), struc-
tural studies and application of these glycoproteins as drugs
to treat human and animal disease.
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